Healthy individuals Other
Conditions
Interventions
Random allocation sequencing was performed by the study statistician. Participants were randomly allocated to two active intervention groups, and a 5% level of significance was chosen (i.e. 95% confid
Sponsors
South East Technological University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy adults, defined as currently/historically not having a chronic disease, having no history of gastrointestinal diseases that could inhibit lutein absorption, having no current severe illnesses or infections, and having not undergone major surgery within the last 6 months 2. Aged between 18 and 65 years old 3. No food allergies 4. Not taking any medications or dietary supplements that would interfere with lutein absorption
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Participants taking medications or supplements known to impact lutein absorption 3. Individuals with allergies to gluten, eggs, and dairy were excluded from the study as the intervention required participants to ingest lutein-fortified foods containing gluten (flour), eggs, and dairy ingredients (butter)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lutein is measured using high-performance liquid chromatography with diode array detection (HPLC-DAD) at baseline, and 3, 6, 10, 24, 48, 72 and 96 hours after taking the lutein-fortified food | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Ireland
Contacts
Public ContactJohn Nolan
Outcome results
None listed